ETF Managers Group’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-540
| Closed | -$17K | – | 704 |
|
|
2022
Q2 | $17K | Buy |
540
+23
| +4% | +$724 | ﹤0.01% | 741 |
|
|
2022
Q1 | $27K | Buy |
517
+2
| +0.4% | +$104 | ﹤0.01% | 679 |
|
|
2021
Q4 | $154K | Sell |
515
-107
| -17% | -$32K | ﹤0.01% | 621 |
|
|
2021
Q3 | $236K | Buy |
622
+172
| +38% | +$65.3K | ﹤0.01% | 608 |
|
|
2021
Q2 | $238K | Sell |
450
-17
| -4% | -$8.99K | ﹤0.01% | 602 |
|
|
2021
Q1 | $244K | Sell |
467
-275
| -37% | -$144K | ﹤0.01% | 603 |
|
|
2020
Q4 | $482K | Buy |
+742
| New | +$482K | 0.01% | 362 |
|